Commodities
Euro area exports to US and UK still significantly lower year-to-date in July
The single currency bloc's surplus on trade with the rest of the world widened in July, nearly completing a V-shaped recovery to pre-Covid levels.
Scottish Power to help produce green hydrogen to fuel transport
Scottish Power’s wind and solar farms are to start producing green hydrogen that will be used to fuel buses, ferries and even trains as part of a strategy to boost the country’s hydrogen economy.
US and UK to enter 4th round of trade talks this week
The resumption of trade talks between the US and the UK later this week will come at a pivotal moment for London as it tries to establish its future relationship with the European Union.
US industrial production weighed down by lower auto output in August
Industrial output in the US undershot economists' forecasts in August, as manufacturing production fell short and that from utilities surprised to the downside.
IEA cuts forecast for global oil demand growth in backhalf 2020
The International Energy Agency took an axe to its forecasts for global oil demand growth in the backhalf of 2020, even as it warned that the world's thirst for oil had, at 91. 7m barrels a day, only recovered to its levels from 2013 due to the pandemic.
German investor sentiment improves in September
German investor sentiment improved in September despite rising coronavirus cases and concerns about Brexit, according to the latest survey from the ZEW Center for European Economic Research in Mannheim.
ByteDance rejects Microsoft offer for TikTok, partners with Oracle instead
Chinese tech company ByteDance has decided to reject Microsoft's bid to buy video app TikTok and partner with Oracle instead.
UK should become global leader in climate action - CBI
The UK should take more action in the fight against climate change and become a global leader on the matter, the CBI Director-General Carolyn Fairbairn will say on Monday.
Eurozone industrial production rises at slower pace
Eurozone industrial production rose in line with expectations in July as Covid-19 but economists warned the rebound was fizzling out.
UN Secretary General calls for $35bn in funding for WHO Covid-19 plan
The United Nation’s Secretary General, Antonio Guterres, said on Thursday that countries should help raise $35bn to fund the World Health Organisation's Covid-19 programme.
US cancels visas for over 1,000 Chinese nationals
The United States revoked visas for over 1,000 Chinese nationals, denying entry to students and researchers deemed security risks, the State Department said on Wednesday.
Euro jumps as ECB keeps mum on currency, dashes hopes for further stimulus
The European Central Bank poured cold water on expectations for further easing and that it would push pack on recent strength in the single currency.
Weekly secondary unemployment and pandemic claims rise in US
Initial US jobless claims were unchanged over the most recent week although secondary claims did edged higher, with some economists saying that the labour market had "stalled".
ECB keeps interest rates unchanged, all eyes on Lagarde's presser
The European Central Bank kept all its main policy settings unchanged, as expected.
Baidu in negotiations to raise $2bn to launch biotech company
Chinese search giant Baidu is negotiating with its investors to raise up to $2bn over three years to launch a new biotech company, reported Reuters on Thursday.
US job openings rise more quickly than expected in July, JOLTS survey shows
Hiring in the US slowed in July but, in a welcome development, the number of job openings picked up, the results of a closely-followed survey revealed.
BioNTech and Pfizer announce positive result in pre-clinical trial for Covid-19 vaccine
One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Google abandons new Dublin office
Google decided to cancel plans to lease a new office in Dublin, Ireland which would have had enough space for 2,000 staff.
AstraZeneca pauses Covid-19 vaccine trial to review safety data
AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a "potentially unexplained illness" in one of the participants.